DK0455510T3 - Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion - Google Patents

Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion

Info

Publication number
DK0455510T3
DK0455510T3 DK91304047.3T DK91304047T DK0455510T3 DK 0455510 T3 DK0455510 T3 DK 0455510T3 DK 91304047 T DK91304047 T DK 91304047T DK 0455510 T3 DK0455510 T3 DK 0455510T3
Authority
DK
Denmark
Prior art keywords
gastric acid
acid secretion
receptor agonist
inhibit gastric
5ht1a receptor
Prior art date
Application number
DK91304047.3T
Other languages
Danish (da)
English (en)
Inventor
John Mehnert Schaus
Jaswant Singh Gidda
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0455510T3 publication Critical patent/DK0455510T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91304047.3T 1990-05-04 1991-05-03 Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion DK0455510T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/519,388 US5096908A (en) 1990-05-04 1990-05-04 Method of inhibiting gastric acid secretion

Publications (1)

Publication Number Publication Date
DK0455510T3 true DK0455510T3 (da) 1997-04-28

Family

ID=24068110

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304047.3T DK0455510T3 (da) 1990-05-04 1991-05-03 Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion

Country Status (14)

Country Link
US (1) US5096908A (fr)
EP (1) EP0455510B1 (fr)
JP (1) JPH04270219A (fr)
KR (5) KR0182791B1 (fr)
AT (1) ATE145553T1 (fr)
AU (1) AU640003B2 (fr)
CA (1) CA2040248C (fr)
DE (1) DE69123286T2 (fr)
DK (1) DK0455510T3 (fr)
ES (1) ES2094792T3 (fr)
GR (1) GR3022466T3 (fr)
HU (1) HU217835B (fr)
PH (1) PH27223A (fr)
ZA (1) ZA913363B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5824680A (en) * 1991-08-31 1998-10-20 Bayer Aktiengesellschaft Ipsapirone for the treatment of alzheimer's disease by improving memory
DK0543584T3 (da) * 1991-11-18 1996-07-01 Lilly Industries Ltd Benzo(b)thiophen-2-carboxamider til behandling af forstyrrelser i centralnervesystemet
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
NZ314570A (en) * 1993-06-10 2000-11-24 Lilly Co Eli Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides
IT1271404B (it) * 1993-08-09 1997-05-28 Hi Chem S P A Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico
FR2712808B1 (fr) * 1993-11-25 1996-02-16 Esteve Labor Dr Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
DK1203761T3 (da) 1994-12-08 2005-04-11 Nps Pharma Inc Calciumreceptoraktive forbindelser
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
JP4117506B2 (ja) 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
WO2000004012A1 (fr) 1998-07-17 2000-01-27 Synaptic Pharmaceutical Corporation COMPOSES SPECIFIQUES DU RECEPTEUR ADRENERGIQUE α1d HUMAIN ET SES UTILISATIONS
AU2002218505A1 (en) * 2000-11-30 2002-06-11 Senju Pharmaceutical Co. Ltd. Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
WO2010021149A1 (fr) * 2008-08-21 2010-02-25 武田薬品工業株式会社 Composé spiro capable d'inhiber une sécrétion d'acide
EP2338873A1 (fr) * 2009-12-22 2011-06-29 Gmeiner, Peter Nouveaux dérivés d'aminotétraline
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2906757A (en) * 1959-09-29 Their preparation
US2922744A (en) * 1957-06-26 1960-01-26 Lilly Co Eli Therapeutic processes employing aminobenzodioxane medicaments
DE1668055B2 (de) * 1967-03-10 1973-09-06 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
ZA855563B (en) * 1984-07-30 1986-05-28 Merrell Dow Pharma Glutarimide antianxiety and antihypertensive agents
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
EP0306375A1 (fr) * 1987-08-07 1989-03-08 Synthelabo Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
CA1331191C (fr) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Derives de la tetraline utiles comme medicaments
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
RU1795965C (ru) * 1988-06-03 1993-02-15 Эли Лилли Энд Компани Способ получени производных пропаноламина или их фармакологически приемлемых кислотно-аддитивных солей.

Also Published As

Publication number Publication date
KR910019615A (ko) 1991-12-19
GR3022466T3 (en) 1997-05-31
KR100188372B1 (ko) 1999-06-01
HU911499D0 (en) 1991-11-28
KR100189590B1 (en) 1999-06-01
KR100188375B1 (en) 1999-06-01
KR0182791B1 (ko) 1999-05-01
JPH04270219A (ja) 1992-09-25
EP0455510A3 (en) 1992-05-06
HUT60918A (en) 1992-11-30
EP0455510B1 (fr) 1996-11-27
AU640003B2 (en) 1993-08-12
CA2040248A1 (fr) 1991-11-05
EP0455510A2 (fr) 1991-11-06
CA2040248C (fr) 2001-06-19
DE69123286T2 (de) 1997-04-24
PH27223A (en) 1993-05-04
ZA913363B (en) 1993-01-27
ATE145553T1 (de) 1996-12-15
ES2094792T3 (es) 1997-02-01
HU217835B (hu) 2000-04-28
AU7607991A (en) 1991-11-07
KR100188373B1 (ko) 1999-06-01
DE69123286D1 (de) 1997-01-09
US5096908A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
DK0455510T3 (da) Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion
DK0657428T3 (da) Fremstilling af 3,4,4-trisubstituerede-piperidinyl-N-alkylcarboxylater og mellemprodukter, der er egnede som opioidantagonister
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
PL287631A1 (en) Method of obtaining novel substituted derivatives of n-/imidazolil/-alkyl-alamine
NO964121D0 (no) Pyrimidin- eller triazin-karboksylsyrederivater for anvendelse som legemidler
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
DK321081A (da) Fremgangsmaade til forhindring af nedbrydning af forbindelser fledt af thieno-pyridiner
ATE20732T1 (de) Halogenierte proteaseinhibitoren.
DK322588A (da) Cycloalkylamider af 6-substituerede (8beta)-1-alkylergoliner og fremgangsmaade til fremstilling af saadanne forbindelser
ITRM930147A0 (it) Procedimento per la preparazione di sali dell'acido clavulanico. (caso 970-9808)
DK1384717T3 (da) 2-(2'Triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronsyre som mellemprodukter til syntese af AII receptorantagonister
ATE79540T1 (de) Pharmazeutische zusammensetzung.
SE9404192D0 (sv) New process
DK356287A (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister
ATE107637T1 (de) 3-arylcarbamoyl-5-aminomethyl-oxazolidine sowie deren salz mit pharmakologisch verträglichen säuren.
DK286090A (da) Alfa-adrenerge receptorantagonister
ITMI911310A1 (it) Procedimento per la preparazione dell'acido 2, 5-diidrossifenilacetico
ITFI910146U1 (it) Plantare correttore alluce valgo per la correzione completa dell' alluce valgo
ATE30675T1 (de) Benzobicyclononanamin-derivate mit antikonvulsiven eigenschaften.